Abiopharma

New Form 10-Q - SUTRO BIOPHARMA, INC. Filed: 2025-08-07 AccNo: 0000950170-25-105219 Size: 13 MB

New Form DEFA14A - Owlet, Inc. Filed: 2025-08-07 AccNo: 0001816708-25-000022 Size: 26 KB

New Form S-8 - Atea Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0001193125-25-175553 Size: 195 KB

New Form 8-K - INTELLIGENT BIO SOLUTIONS INC. Filed: 2025-08-07 AccNo: 0001493152-25-011706 Size: 225 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Ginkgo Bioworks Reports Second Quarter 2025 Financial Results

ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics

New Form 4 - AbbVie Inc. Filed: 2025-08-07 AccNo: 0001415889-25-021280 Size: 7 KB

New Form 4 - Disc Medicine, Inc. Filed: 2025-08-07 AccNo: 0001415889-25-021281 Size: 8 KB

New Form 4 - Vigil Neuroscience, Inc. Filed: 2025-08-07 AccNo: 0001415889-25-021282 Size: 17 KB

New Form 10-Q - Quoin Pharmaceuticals, Ltd. Filed: 2025-08-07 AccNo: 0001410578-25-001613 Size: 4 MB

New Form 4 - BECTON DICKINSON & CO Filed: 2025-08-07 AccNo: 0000010795-25-000077 Size: 5 KB

New Form 8-K - Quoin Pharmaceuticals, Ltd. Filed: 2025-08-07 AccNo: 0001104659-25-075244 Size: 279 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 6-K - GALAPAGOS NV Filed: 2025-08-07 AccNo: 0001171843-25-005188 Size: 9 KB

New Form 10-Q - Vistagen Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001411685-25-000064 Size: 4 MB

New Form 4 - iRhythm Technologies, Inc. Filed: 2025-08-07 AccNo: 0001850152-25-000005 Size: 5 KB